Jean-Pierre Kinet

This inventor holds 15 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 5 EPO patents. Top assignees: Ab Science, Beth Israel Deaconess Medical Center, Inc., Heska Corporation. Active years: 1999-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Pierre Kinet. Retrieved from https://idiyas.com/inventor/jean-pierre-kinet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 (Patent Applications = 9)

% Patents Active = 73.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 8)

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

Aix-en-Provence, FR (2014 - 2018)
Lexington, MA (US) (1999 - 2019)

Company Filing History:

Beth Israel Deaconess Medical Center, Inc.

Assistance Publique-Hopitaux De Paris

patents

5. 1 out of 5

Imagine Institut Des Maladies Genetiques Necker Enfants Malades

patents

6. 1 out of 1,853

National Institute of Health and Medical Research

Universite Paris Cité

patents

where one patent can have more than one assignee

Years Active: 1999-2025

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12472164 - Masitinib for the treatment of sickle cell disease (2025-11-18),

2. 10238649 - Use of masitinib for treatment of cancer in patient subpopulations identified using predictor factors (2019-03-26),

3. 10092564 - Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation (2018-10-09),

4. 10045978 - Treatment of mastocytosis with masitinib (2018-08-14),

5. 9078894 - Treatment of severe persistant asthma with masitinib (2015-07-14),

6. 8906357 - Treatment of multiple sclerosis with masitinib (2014-12-09),

7. 8450302 - 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors (2013-05-28),

8. 8227470 - Combination treatment of solid cancers with antimetabolites and tyrosine kinase inhibitors (2012-07-24),

9. 7811568 - Smallpox monoclonal antibody (2010-10-12),

10. 7700610 - Use of tyrosine kinase inhibitors for treating allergic diseases (2010-04-20),

11. 7678805 - Use of tyrosine kinase inhibitors for treating inflammatory bowel diseases (IBD) (2010-03-16),

12. 7026283 - Calcium-independent negative regulation by CD81 of receptor signalling (2006-04-11),

13. 6423501 - Calcium-independent negative regulation by CD81 of receptor signaling (2002-07-23),

14. 6165799 - Detection of anti-Fc.sub..epsilon. R autoantibodies in asthmatics (2000-12-26),

15. 5965605 - Inhibition of the binding human IgE to its receptor by tetracyclic (1999-10-12),

Title: The Inventor Jean-Pierre Kinet

Introduction: Jean-Pierre Kinet is a renowned inventor based in Lexington, MA (US) known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean-Pierre Kinet holds several patents in the areas of robotics, artificial intelligence, and renewable energy technologies, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With a career spanning over two decades, Jean-Pierre Kinet has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Jean-Pierre Kinet has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to numerous successful projects and inventions.

Conclusion: Jean-Pierre Kinet's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.